Fluoromethylcholine PET in recurrent multifocal hepatoma.
F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has variable efficacy in evaluating hepatocellular carcinoma. We present a case of a new oncologic imaging tracer fluoromethylcholine (FCH), which has visualized recurrent multifocal hepatoma in a patient with a poor FDG avid hepatic tumour. The lesions demonstrated on FCH PET correlated well with the findings on CT hepatic angiography.
Lenzo
N P
NP
WA PET/Cyclotron Service, Sir Charles Gairdner Hospital, Perth, Australia. nlenzo@mac.com
Anderson
J
J
Campbell
A
A
Morandeau
L
L
De Grado
T R
TR
D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging*; D002794:Choline / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D008113:Liver Neoplasms / Q000000981:diagnostic imaging*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals
D019275:Radiopharmaceuticals; C516370:fluoromethylcholine; D002794:Choline